Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Unknown 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hyperthermia 10 Uterine Cervical Neoplasms 2 Rectal Neoplasms 2 Head and Neck Neoplasms 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1

Interventions

Doxorubicin 15 pembrolizumab 12 Surgical Procedures, Operative 8 Cyclophosphamide 8 Blood Specimen Collection 8 Ifosfamide 7 Gemcitabine 7 Surveys and Questionnaires 6 Nivolumab 6 Trabectedin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Drug Therapy 5 atezolizumab 4 Temozolomide 4 Specimen Handling 4 Radiation Dose Hypofractionation 4 Biopsy 4 pazopanib 3 liposomal doxorubicin 3 fludarabine 3 cabozantinib 3 anlotinib 3 Radiation 3 Observation 3 Docetaxel 3 Dacarbazine 3 trastuzumab deruxtecan 2 toripalimab 2 selinexor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Diathermy × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡